000 01129 a2200349 4500
005 20250517055338.0
264 0 _c20160726
008 201607s 0 0 eng d
022 _a1875-8630
024 7 _a10.1155/2015/316739
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoričar, Katja
245 0 0 _aSerum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
_h[electronic resource]
260 _bDisease markers
_c2015
300 _a316739 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInhibitor of Apoptosis Proteins
_xblood
650 0 4 _aMale
650 0 4 _aMesothelioma
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aSurvivin
700 1 _aKovač, Viljem
700 1 _aFranko, Alenka
700 1 _aDodič-Fikfak, Metoda
700 1 _aDolžan, Vita
773 0 _tDisease markers
_gvol. 2015
_gp. 316739
856 4 0 _uhttps://doi.org/10.1155/2015/316739
_zAvailable from publisher's website
999 _c25338638
_d25338638